134 related articles for article (PubMed ID: 37606200)
21. Clear-cell Variant of Mucoepidermoid Carcinoma Presenting as a Palatal Mass in a 10-Year-old Boy.
Han SH; O'Toole TR; Meyer RG; Geiersbach KB; Islam MN; Cheng L; Lai J
Anticancer Res; 2023 Feb; 43(2):939-942. PubMed ID: 36697075
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
23. Mucoepidermoid carcinoma of the esophagus with MAML2 gene rearrangement: Case report and literature review.
Chen R; Wang B; Li L; Xue L
Pathol Res Pract; 2023 Jan; 241():154242. PubMed ID: 36481651
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Warthin-like Mucoepidermoid Carcinoma: Report of Two Cases with One Persistent/Recurrent as Conventional Mucoepidermoid Carcinoma.
Daoud EV; McLean-Holden AC; Pfeifer CM; Timmons CF; Oliai BR; Bishop JA
Head Neck Pathol; 2020 Dec; 14(4):923-928. PubMed ID: 32221865
[TBL] [Abstract][Full Text] [Related]
25. A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells.
Tajima S; Namiki I; Koda K
Med Mol Morphol; 2017 Jun; 50(2):117-121. PubMed ID: 26297211
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic and prognostic implications of MAML2 gene translocation in primary pulmonary mucoepidermoid carcinoma].
Luo DL; Yan JH; Ge Y; Yan LX; Chen J; Xu J; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):26-30. PubMed ID: 30641642
[No Abstract] [Full Text] [Related]
27. Conjunctival Adenosquamous Carcinoma Lacks
Lee A; Yuen HKL; Tham CCY; Cheuk W
Int J Surg Pathol; 2020 Dec; 28(8):893-898. PubMed ID: 32476556
[TBL] [Abstract][Full Text] [Related]
28. Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours.
Bishop JA; Thompson LDR; Siegele B; Gagan J; Mansour M; Chernock RD; Rooper LM
Histopathology; 2023 Jan; 82(2):305-313. PubMed ID: 36208053
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
[TBL] [Abstract][Full Text] [Related]
30. A high-grade breast mucoepidermoid carcinoma without MAML2 rearrangement: A case report and literature review.
Wang L; Cheng D; Wang H; Cheng L; Zhang X
Medicine (Baltimore); 2024 Feb; 103(8):e37163. PubMed ID: 38394503
[TBL] [Abstract][Full Text] [Related]
31. Mucoepidermoid carcinoma: a five-decade journey.
Chenevert J; Barnes LE; Chiosea SI
Virchows Arch; 2011 Feb; 458(2):133-40. PubMed ID: 21243374
[TBL] [Abstract][Full Text] [Related]
32. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
[TBL] [Abstract][Full Text] [Related]
33. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.
Martins C; Cavaco B; Tonon G; Kaye FJ; Soares J; Fonseca I
J Mol Diagn; 2004 Aug; 6(3):205-10. PubMed ID: 15269296
[TBL] [Abstract][Full Text] [Related]
34. Central mucoepidermoid carcinoma arising from glandular odontogenic cyst confirmed by analysis of MAML2 rearrangement: A case report.
Nagasaki A; Ogawa I; Sato Y; Takeuchi K; Kitagawa M; Ando T; Sakamoto S; Shrestha M; Uchisako K; Koizumi K; Toratani S; Konishi M; Takata T
Pathol Int; 2018 Jan; 68(1):31-35. PubMed ID: 29131467
[TBL] [Abstract][Full Text] [Related]
35. Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma.
Roden AC; García JJ; Wehrs RN; Colby TV; Khoor A; Leslie KO; Chen L
Mod Pathol; 2014 Nov; 27(11):1479-88. PubMed ID: 24743219
[TBL] [Abstract][Full Text] [Related]
36. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases.
Baloch ZW; Solomon AC; LiVolsi VA
Mod Pathol; 2000 Jul; 13(7):802-7. PubMed ID: 10912941
[TBL] [Abstract][Full Text] [Related]
37. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
38. A child with a t(11;19)(q14-21;p12) in a pulmonary mucoepidermoid carcinoma.
Stenman G; Petursdottir V; Mellgren G; Mark J
Virchows Arch; 1998 Dec; 433(6):579-81. PubMed ID: 9870694
[TBL] [Abstract][Full Text] [Related]
39. Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment.
Han SW; Kim HP; Jeon YK; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Heo DS; Bang YJ; Kim TY
Lung Cancer; 2008 Jul; 61(1):30-4. PubMed ID: 18192072
[TBL] [Abstract][Full Text] [Related]
40. Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis.
Rossi G; Sartori G; Cavazza A; Tamberi S
Lung Cancer; 2009 Jan; 63(1):159-60. PubMed ID: 18992960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
